Business
Avalon GloboCare Eliminates Majority of Debentures Through $2.6 Million Conversion, Strengthening Balance Sheet, Reduces Overhang
Conversion Improves Capital Structure, and Reinforces Nasdaq Compliance, Enhancing Shareholder Value Company Believes That Substantially All of the Converted Shares Have Been Sold FREEHOLD, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer products and generative AI publishing and software, today announced the conversion of the majority of its outstanding deb
About this update from Avalon Globocare Corp.
[{"type":"image","alt":"Avalon GloboCare Corp.","displaySize":"","headline":null,"caption":"Avalon GloboCare Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":79,"url":"https://media.zenfs.com/en/globenewswire.com/ca14a367dd280e883fb2c073629a950a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/f2z2WLiGU9diHcPeWDzacQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExMTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/ca14a367dd280e883fb2c073629a950a","width":300,"height":79}},"lazy":false},{"type":"text","content":"Conversion Improves Capital Structure, and Reinforces Nasdaq Compliance, Enhancing Shareholder Value","length":100,"tagName":"p"},{"type":"text","content":"Company Believes That Substantially All of the Converted Shares Have Been Sold","length":78,"tagName":"p"},{"type":"text","content":"FREEHOLD, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer products and generative AI publishing and software, today announced the conversion of the majority of its outstanding debentures, significantly strengthening the Company’s balance sheet.","length":385,"tagName":"p"},{"type":"text","content":"The debentures originated from a June 2024 institutional investor convertible note financing with an aggregate principal amount of $2.8 million. Of this amount, $288 thousand of principal was repaid in cash, while the remaining $2.6 million of principal was converted into shares of Avalon’s common stock in accordance with the terms of the debentures, eliminating the majority of Avalon’s outstanding debt. The Company believes that substantially all of the converted shares have been sold.","length":491,"tagName":"p"},{"type":"text","content":"The Company believes the debenture conversion removes a significant balance-sheet overhang, improves financial transparency, and supports long-term shareholder value creation as Avalon continues advancing its diagnostic, intellectual property, and AI-driven initiatives.","length":270,"tagName":"p"},{"type":"text","content":"“This conversion represents a meaningful milestone for Avalon,” said Meng Li, Avalon’s Interim Chief Executive Officer and Chief Operating Officer. “By substantially reducing debt, we have strengthened our capital structure, enhanced...